Parkinson s UK Implements CDD Vault to Manage Its Pioneering Drug Discovery Data
USA - English
Share this article
Share this article
LONDON and SAN FRANCISCO, July 19, 2021 /PRNewswire/ Parkinson s UK, the largest charitable funder of Parkinson s research in Europe, has announced today that it is using Collaborative Drug Discovery s CDD Vault informatics system to manage project data from the Parkinson s Virtual Biotech, its pioneering drug discovery arm.
The Parkinson s Virtual Biotech, which launched in 2017, is a program that is plugging the funding gap in drug development to fast-track the projects with the greatest scientific potential to transform the lives of people with Parkinson s. As part of the collaboration, CDD Vault will help the charity keep its research data safe and secure. It will also enable scientists to analyze data and design the next set of biological molecules.
Parkinson’s UK, University of Sheffield to develop new Parkinson’s drug
Parkinson s UK, the largest charitable funder of Parkinson s research in Europe, is investing up to £1.2 million into a pioneering one-year project in partnership with the University of Sheffield.
The project aims to refine a molecule that could be developed into a drug to protect dopamine-producing brain cells and slow down the progression of Parkinson s.
The funding boost comes via the charity s Parkinson s Virtual Biotech initiative, which is plugging the funding gap in drug development and fast-tracking the development of new treatments for people with Parkinson s.
Scientists at the University of Sheffield s Institute of Translational Neuroscience (SITraN) and Parkinson s UK have been developing molecules that can boost the function of the brain s energy-producing mitochondria, to halt Parkinson s - something no treatment can currently do.
Researchers from the University of Sheffield's Institute of Translational Neuroscience (SITraN) have been awarded over £1 million from Parkinson's UK to.
UK charity provides £1.2 million ($1.7 million) in funding to refine molecule to protect dopamine-producing brain cells and slow down disease progression.
Parkinson s UK invests £1 2m in drug design project pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.